{
    "title": "106_hr1039",
    "content": "SECTION 1. CREDIT FOR CLINICAL TESTING RESEARCH EXPENSES ATTRIBUTABLE TO CERTAIN QUALIFIED ACADEMIC INSTITUTIONS INCLUDING TEACHING HOSPITALS. Amends the Internal Revenue Code to include a credit for medical innovation expenses. The medical innovation credit under section 38 is 20% of qualified medical innovation expenses exceeding the medical innovation base period amount. Qualified expenses are payments to qualified academic institutions for clinical testing research activities before product approval. The term 'product' refers to drugs, biologics, or medical devices approved under specific sections of relevant acts. A 'qualified academic institution' is defined as certain educational institutions affiliated with research activities for product approval. The curr_chunk describes different types of organizations affiliated with institutions of higher education for specific purposes, such as teaching hospitals, medical research organizations, and charitable research hospitals designated as cancer centers by the National Cancer Institute. The curr_chunk discusses the definition of qualified medical innovation expenses and the medical innovation base period amount for tax purposes, along with special rules like the limitation on foreign testing for clinical research activities. The section outlines rules for applying the tax credit for qualified medical innovation expenses, including the requirement for taxpayer election and coordination with other research credits. It also specifies the termination date for eligibility. The credit is integrated into the general business credit under Section 38(b) of the tax code. The tax code is amended to include a medical innovation expenses credit under section 41A. A transition rule prohibits carrying back the credit before January 1, 1999. A denial of double benefit is specified for qualified medical innovation expenses. The tax code is amended to include a medical innovation expenses credit under section 41A, with rules similar to other subsections. A deduction for the unused portion of the credit is also specified in section 196(c), and a clerical amendment is made to the table of sections. The tax code is amended to include a medical innovation expenses credit under section 41A, effective for taxable years starting after December 31, 1998."
}